224 related articles for article (PubMed ID: 6543318)
1. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
Crovato E; Salvini R
Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2255-60. PubMed ID: 6543318
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y
Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
[TBL] [Abstract][Full Text] [Related]
3. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
[TBL] [Abstract][Full Text] [Related]
4. [NAG (N-acetyl-beta-D-glucosaminidase)--a sensitive marker for disorders of kidney function].
Skrezek C; Bertermann H; Schulz FP; König B
Urologe A; 1990 Jan; 29(1):27-31. PubMed ID: 2316078
[TBL] [Abstract][Full Text] [Related]
5. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)].
Oudart N; Marcher K; Lacour B; Boulu RG; Guichard C
Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165
[TBL] [Abstract][Full Text] [Related]
6. Analysis of urinary N-acetyl-beta-D-glucosaminidase isozyme in patients treated with gentamicin or cis-diammine dichloroplatinum (II).
Aikawa A; Hata M; Nakamura H
Dev Toxicol Environ Sci; 1986; 14():183-6. PubMed ID: 3829974
[No Abstract] [Full Text] [Related]
7. Urinary N-acetyl-beta-D-glucosaminidase (NAG) as an indicator of renal disease.
Price RG
Curr Probl Clin Biochem; 1979; (9):150-63. PubMed ID: 446070
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
Naruse T; Hirokawa N; Oike S; Maekawa T
Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
[TBL] [Abstract][Full Text] [Related]
10. [Urinary NAG and gamma-GTP activities as indicators of CDDP renal toxicity: effect of fosfomycin on CDDP renal toxicity].
Yoshida K; Takahashi T; Nakame Y; Saitoh H; Horiuchi S; Kaneoya F; Negishi T
Hinyokika Kiyo; 1986 Sep; 32(9):1237-45. PubMed ID: 2880486
[TBL] [Abstract][Full Text] [Related]
11. [Studies of urinary proteins, FDP (fibrinogen degradation products), and NAG (N-acetyl-beta-D-glucosaminidase) in renal transplanted patients].
Kunikata S; Ikegami M; Imanishi M; Nishioka T; Ishii T; Uemura T; Kanda H; Matsuura T; Akiyama T; Kurita T
Hinyokika Kiyo; 1989 Aug; 35(8):1299-304. PubMed ID: 2816597
[TBL] [Abstract][Full Text] [Related]
12. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases].
Yakata M; Sugita O; Sakai T; Uchiyama K; Wada K
Rinsho Byori; 1983 Sep; Spec No 56():90-101. PubMed ID: 6663765
[No Abstract] [Full Text] [Related]
13. [Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients with urological disease: with special reference to hydronephrosis].
Ueda K; Kato J; Seki T
Hinyokika Kiyo; 1984 Jul; 30(7):877-82. PubMed ID: 6391119
[TBL] [Abstract][Full Text] [Related]
14. Urinary N-acetyl-beta-D-glucosaminidase in the patients with hyperthyroidism.
Tominaga M; Fujiyama K; Hoshino T; Tanaka Y; Takeuchi T; Honda M; Mokuda O; Ikeda T; Mashiba H
Horm Metab Res; 1989 Aug; 21(8):438-40. PubMed ID: 2793065
[TBL] [Abstract][Full Text] [Related]
15. [Influence of aminoglycosides on the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes].
Mozer JL; Gibey R; Dupond JL; Henry JC
Pathol Biol (Paris); 1988 Mar; 36(3):230-4. PubMed ID: 3283685
[TBL] [Abstract][Full Text] [Related]
16. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.
Hultberg B; Ravnskov U
Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750
[TBL] [Abstract][Full Text] [Related]
17. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases].
Suzuki M; Asano Y
Rinsho Byori; 1983 Sep; Spec No 56():139-46. PubMed ID: 6663755
[No Abstract] [Full Text] [Related]
18. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum.
Diener U; Knoll E; Langer B; Rautenstrauch H; Ratge D; Wisser H
Clin Chim Acta; 1981 May; 112(2):149-57. PubMed ID: 6113066
[TBL] [Abstract][Full Text] [Related]
19. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts].
Ishida Y; Kawada T; Sugino N
Rinsho Byori; 1983 Sep; Spec No 56():160-7. PubMed ID: 6363758
[No Abstract] [Full Text] [Related]
20. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 2. Preclinical determination of the urinary NAG activities and the test data of patients admitted for multiphasic screening].
Kiyose H; Tomii M; Shimomura H; Mizuno E; Taguchi I; Inoue Y
Rinsho Byori; 1983 Sep; Spec No 56():73-8. PubMed ID: 6663763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
